Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study

(2019) Louis Létinier et al.   Frontiers in Pharmacology

Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe

(2018) Karima Hider-Mlynarz et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France

(2017) P. Tuppin et al.   REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE

Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies

(2016) Aurore Palmaro et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Surveillance of Physicians Causing Potential Drug-Drug Interactions in Ambulatory Care: A Pilot Study in Switzerland

(2016) Heiner C. Bucher et al.   PLoS One

Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions

(2015) S Hennessy et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features

(2015) Consuelo Pedrós et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Reducing Inappropriate Polypharmacy

(2015) Ian A. Scott et al.   JAMA Internal Medicine

Prevalence of the Prescription of Potentially Interacting Drugs

(2013) Elena Tragni et al.   PLoS One

Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption

(2009) Sabine Gaubert et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Using Secondary Data Sources for Pharmacoepidemiology and Outcomes Research

(2009) Spencer E Harpe   PHARMACOTHERAPY